IL-6-174 C/G polymorphism in the gastroenteropancreatic neuroendocrine tumors (GEP-NETs)

Experimental and Molecular Pathology

Volumn 83, Issue 3, 2007, Pages 474-479

  Berković, Maja Cigrovski ^a   Jokić, Mladen ^b   Marout, Jasminka ^a   Radošević, Senka ^c   Zjačić Rotkvić, Vanja ^a   Kapitanović, Sanja ^b  

^a SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

^b RUDER BO KOVI INSTITUTE   (Croatia)

^c PLIVA CROATIA LTD   (Croatia)

Author keywords

GEP NET; IL 6, 174 G C promoter SNP; PET

Indexed keywords

INTERLEUKIN 6;

AGED; ANALYSIS OF VARIANCE; ARTICLE; BLOOD LEVEL; CHEMOLUMINESCENCE; CHI SQUARE TEST; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; FEMALE; FISHER EXACT TEST; GASTROENTEROPANCREATIC NEUROENDOCRINE TUMOR; GENE EXPRESSION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; IL 6 174 G/C GENE; MAJOR CLINICAL STUDY; MALE; NEUROENDOCRINE TUMOR; POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE;

FEMALE; GASTROINTESTINAL NEOPLASMS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; NEUROENDOCRINE TUMORS; PANCREATIC NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES;

EID: 36049025254     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2007.08.018     Document Type: Article

References (26)

1. Barakat M.T., Meeren K., and Bloom S.R. Neuroendocrine tumors. Endocr.-Relat. Cancer 11 (2004) 1-18
2. Bidwell J., Keen L., Gallagher G., Kimberly R., Huizinga T., McDermott M.F., Oksenberg J., McNicholl J., Pociot F., Hardt C., and D'Alfonso S. Cytokine gene polymorphism in human disease: on-line databases. Genes Immun. 1 (1999) 3-19
3. Chung Y.C., and Chang Y.F. Serum interleukin-6 levels reflect the disease status of colorectal cancer. J. Surg.Oncol. 83 (2003) 222-226
4. Coussens L.M., and Werb Z. Inflammation and cancer. Nature 420 (2002) 860-867
5. DeMichele A., Martin A.M., Mick R., Gor P., Wray L., Klein-Cabral M., Athanasiadis G., Colligan T., Stadtmauer E., and Weber B. Interleukin-6-174 G → C polymorphism is associated with improved outcome in high-risk breast cancer. Cancer Res. 63 (2003) 8051-8056
6. DeVita F., Romano C., Orditura M., Galizia G., Martinelli E., Lieto E., and Catalano G. Interleukin-6 serum level correlates with survival in advanced gastrointestinal cancer patients but is not an independent prognostic indicator. J. Interferon Cytokine Res. 21 (2001) 45-52
7. Diehl S., and Rincon M. The two faces of IL-6 on Th1/Th2 differentiation. Mol. Immunol. 39 (2002) 531-536
8. Falchetti A., and Brandi M.L. Genetic testing for multiple endocrine neoplasias. Endocr.-Relat. Cancer 5 (1998) 37-44
9. Fishman D., Faulds G., Jeffery R., Mohamed-Ali V., Yudkin J.S., Humphries S., and Woo P. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J. Clin. Invest. 102 (1998) 1369-1376
10. Haukim N., Bidwell J.L., Smith A.J., Keen L.J., Gallagher G., Kimberly R., Huizinga T., McDermott M.F., Oksenberg J., McNicholl J., Pociot F., Hardt C., and D'Alfonso S. Cytokine gene polymorphism in human disease: on-line data bases, Suppl 2. Genes Immun. (2002) 313-330
11. Hefler L.A., Grimm C., Ackermann S., Malur S., Radjabi-Rahat A.R., Leodolter S., Beckmann M.W., Zeillinger R., Koelbl R., and Tempfer C.B. An interleukin-6 promoter polymorphism influences the biological phenotype of ovarian cancer. Cancer Res. 63 (2003) 3066-3068
12. Hefler L.A., Grimm C., Lantzsch T., Lampe D., Leodolter S., Koelbl H., Heinze G., Reinthaller A., Tong-Cascire D., Tempfer C., and Zeilinger R. Interleukin-1 and Interleukin-6 gene polymorphisms and the risk of breast cancer in Caucasian women. Clin. Cancer Res. 11 (2005) 5718-5721
13. Huang S.P., Wu M.S., Wang P.H., Yang S.C., Kuo M.L., and Lin J.T. Correlation between serum levels of interleukin 6 and vascular endothelial growth factor in gastric carcinoma. J. Gastroenterol. Hepatol. 17 (2002) 1165-1169
14. Iacopetta B., Grieu F., and Joseph D. The-174 G/C gene polymorphism in interleukin-6 is associated with an aggressive breast cancer phenotype. Br. J. Cancer 90 (2004) 419-422
15. Kinoshita T., Ito H., and Miki C. Serum IL-6 level reflects the tumor proliferative activity in patients with colorectal cancer. Cancer 85 (1999) 2526-2531
16. Macarthur M., Hold G.L., and El-Omar E.M. Inflammation and cancer II. Role of chronic inflammation and cytokine gene polymorphisms in the pathogenesis of gastrointestinal malignancy. Am. J. Physiol.: Gasterointest. Liver Physiol. 286 (2004) G515-G520
17. Nakashima J., Tachibana M., Horiguchi Y., Oya M., Ohigashi T., Asakura H., and Murai M. Serum interleukin-6 as prognostic factor in patients with prostate cancer. Clin. Cancer Res. 6 (2000) 2707-2706
18. Okada S., Okusaka T., Ishii H., Kyogoku A., Yoshimori M., Kajimura N., Yamaguchi K., and Kakizoe T. Elevated interleukin-6 serum levels in patients with pancreatic cancer. Jpn. J. Clin. Oncol. 28 (1998) 12-15
19. Rindi G., and Bordi C. Highlights of the biology of endocrine tumors of the gut and pancreas. Endocr.-Relat. Cancer 10 (2003) 427-436
20. Saito K., Ishikura H., Kishimoto T., Kawarada Y., Yano T., Takahashi T., Kato H., and Yoshki T. Interleukin-6 produced by pancreatic carcinoma cells enhances humoral immune responses against tumor cells: a possible event in tumor regression. Int. J. Cancer 75 (1998) 284-289
21. Savage S.A., Abnet C.C., Haque K., Mark S.D., Qiao Y.L., Dong Z.W., Dawsey S.M., Taylor P.R., and Chanock S.J. Polymorphisms in interleukin-2,-6 and-10 are not associated with gastric cardia or esophagela cancer in a high risk Chinese population. Cancer Epidemiol. Biomark. Prev. 13 (2004) 1547-1549
22. Spaventi R., Pečur L., Pavelić K., Pavelić Z.P., Spaventi Š., and Stambrook P.J. Human tumor bank in Croatia: a possible model for small bank as a part of the future European Tumor Bank Network. Eur. J. Cancer 30A (1994) 419
23. Speel E.J., Scheidweiler A.F., Zhao J., Matter C., Saremaslani P., Roth J., Heitz P.U., and Komminoth P. Genetic evidence for early divergence of small functioning and nonfunctioning endocrine pancreatic tumors: gain of 9Q34 is an early event in insulinomas. Cancer Res. 61 (2001) 5186-5192
24. Tsukamoto T., Kumamoto Y., Miyao N., Masumori N., Takahashi A., and Yanase M. Interleukin-6 in renal cell carcinoma. J. Urol. 148 (1992) 1778-1782
25. Wiedenmann B., and Pape U.F. From basic to clinical research in gastroenteropancreatic neuroendocrine tumor disease-the clinician-scientist perspective. Neuroendocrinology 80 suppl 1 (2004) 94-98
26. Zhao J., Moch H., Scheidweiler A.F., Baer A., Schäffer A.A., Speel E.J., Roth J., Heitz P.U., and Komminoth P. Genomic imbalances in the progression of endocrine pancreatic tumors. Genes Chromosomes Cancer 29 (2001) 83-87